Telix Pharmaceuticals Ltd (OTCPK:TLPPF)
$ 10.45 0.15 (1.46%) Market Cap: 3.41 Bil Enterprise Value: 3.34 Bil PE Ratio: 966.88 PB Ratio: 33.63 GF Score: 78/100

Telix Pharmaceuticals Ltd ASCO-GU ZIRCON Phase III Results Presentation Transcript

Feb 20, 2023 / 09:30PM GMT
Kyahn Williamson
Telix Pharmaceuticals Limited - SVP of Corporate Communications & IR

Presentation
Feb 20, 2023 / 09:30PM GMT

=====================
Corporate Participants
=====================
* Colin Hayward
Telix Pharmaceuticals Limited - Group Chief Medical Officer
* Kyahn Williamson
Telix Pharmaceuticals Limited - SVP of Corporate Communications & IR

=====================
Conference Call Participants
=====================
* Dennis Hulme
Taylor Collison Limited, Research Division - Biotech & Healthcare Analyst
* Shane A. Storey
Wilsons Advisory and Stockbroking Limited, Research Division - Senior Analyst
* Steven David Wheen
Jarden Australia Pty Limited, Research Division - Head of Healthcare, Equity Research
* Brian M. Shuch

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot